Peripheral T-cell lymphoma after anti-CD20 antibody therapy.
Tetreault
S
S
Abler
S L
SL
Robbins
B
B
Saven
A
A
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D008212:Lymphocyte Depletion; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D016411:Lymphoma, T-Cell, Peripheral / Q000139:chemically induced* / Q000473:pathology; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab